骨膜蛋白促进实验性肺动脉高压进展:M2巨噬细胞与FGF-2信号的作用
该研究在Sugen5416联合缺氧(SuHx)及野百合碱吡咯(MCT-P)两种实验性肺动脉高压模型中,比较野生型与骨膜蛋白基因敲除小鼠,发现骨膜蛋白缺失可减轻肺动脉高压、肺小动脉重塑及M2巨噬细胞聚集。体外实验显示转化生长因子-β促进骨膜蛋白分泌,骨膜蛋白增强巨噬细胞及肺血管细胞迁移;肺动脉高压患者血清骨膜蛋白水平显著高于健康对照。
要点
- 骨膜蛋白缺失减轻两种实验性肺动脉高压及肺小动脉M2巨噬细胞聚集
- 骨膜蛋白增强巨噬细胞、肺动脉平滑肌与内皮细胞迁移
- 肺动脉高压患者血清骨膜蛋白水平显著高于健康对照
核心结论
- 骨膜蛋白参与不同类型实验性肺动脉高压的发生发展,并可能参与人类肺动脉高压的发病。
- 骨膜蛋白缺失可减轻SuHx和MCT-P诱导的肺动脉高压及M2巨噬细胞向肺小动脉的聚集。
- SuHx后骨膜蛋白缺失小鼠的肺动脉重塑较野生型小鼠轻。
- SuHx骨膜蛋白缺失小鼠肺组织巨噬细胞相关趋化因子与FGF-2表达及右心室CD68阳性细胞聚集少于野生型。
- 肺动脉高压患者血清骨膜蛋白水平显著高于健康对照。
研究设计与样本
- 在野生型和骨膜蛋白基因敲除小鼠中,用血管内皮生长因子受体拮抗剂Sugen5416联合缺氧(SuHx)及静脉注射野百合碱吡咯(MCT-P)诱导肺动脉高压。
- 检测肺动脉血流动力学、肺动脉重塑、趋化因子与FGF-2表达、巨噬细胞向肺小动脉及右心室聚集。
- 体外研究骨膜蛋白对巨噬细胞、人肺动脉平滑肌细胞(HPASMCs)和人肺微血管内皮细胞(HPMVECs)迁移的作用。
主要发现
- SuHx和MCT-P诱导的肺动脉高压中,骨膜蛋白缺失小鼠的肺动脉高压及M2巨噬细胞向肺小动脉聚集均减轻。
- SuHx处理后骨膜蛋白缺失小鼠的肺动脉重塑较野生型小鼠轻。
- SuHx骨膜蛋白缺失小鼠肺组织巨噬细胞相关趋化因子与FGF-2表达、右心室CD68阳性细胞聚集均少于SuHx野生型小鼠。
- 转化生长因子-β增强HPASMCs和HPMVECs的骨膜蛋白分泌。
- 骨膜蛋白增强巨噬细胞、HPASMCs和HPMVECs的迁移。
临床怎么用
- 骨膜蛋白及其下游M2巨噬细胞与FGF-2信号可能成为肺动脉高压的潜在干预靶点。
- 血清骨膜蛋白或可作为肺动脉高压的生物标志物线索,尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Remodelling of pulmonary arteries (PA) contributes to the progression of pulmonary hypertension (PH). Periostin, a matricellular protein, has been reported to be involved in the development of PH. We examined the role of periostin in the pathogenesis of PH using different types of experimental PH. METHODS: PH was induced by vascular endothelial growth factor receptor antagonist (Sugen5416) plus hypoxic exposure (SuHx) and venous injection of monocrotaline-pyrrole (MCT-P) in wild-type (WT) and periostin-/- mice. Pulmonary haemodynamics, PA remodelling, expression of chemokines and fibroblast growth factor (FGF)-2, accumulation of macrophages to small PA and the right ventricle (RV) were examined in PH-induced WT and periostin-/- mice. Additionally, the role of periostin in the migration of macrophages, human PA smooth muscle (HPASMCs) and endothelial cells (HPMVECs) was investigated. RESULTS: In PH induced by SuHx and MCT-P, PH and accumulation of M2 macrophage to small PA were attenuated in periostin-/- mice. PA remodelling post-SuHx treatment was also mild in periostin-/- mice compared to WT mice. Expression of macrophage-associated chemokines and FGF-2 in lung tissue, and accumulation of CD68-positive cells in the RV were less in SuHx periostin-/- than in SuHx WT mice. Periostin secretion in HPASMCs and HPMVECs was enhanced by transforming growth factor-β. Periostin also augmented macrophage, HPASMCs and HPMVECs migration. Separately, serum periostin levels were significantly elevated in patients with PH compared to healthy controls. CONCLUSION: Periostin is involved in the development of different types of experimental PH, and may also contribute to the pathogenesis of human PH.
引用
- Yoshida T, Nagaoka T, Nagata Y, et al. Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling. Respirology. 2022. PMID: 35318760. doi:10.1111/resp.14249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。